16th Annual Patient Recruitment and Retention Summit
Event is Over
Stay Updated for 2025 edition
Past Speakers
SEE THE PREVIOUS SPEAKERS & CASE STUDIES
CASE STUDY
Use of the Ethereum Blockchain Platform for Data Integrity and Security Management in Clinical Trials
The recent massive security breaches and data theft in the healthcare industry have made managing patient identities a very real problem. The blockchain can provide us with relevant solutions. Every pointer doctor records on the blockchain would become part of the patient’s record, regardless of the CRF that was used. The new tech transforms the data entry, and converts researchers into miners. The Tokenisation of Clinical Trials is coming and that is possible since the Ethereum Frontier repository was public in 2015. Considering an actual PESTELE analysis we can outline the risk, the weaknesses of a pharma or biotech at the present time. The presentation also emphasises the modification of Porter’s forces to make strategic decisions.
- 01Blockchain and GDRP (UE) 2016/679
- 02Mining requirements
- 03Healthcoins
CASE STUDY
Patient Experience Milestones in Clinical Trials: From Voice to Value
We delve into the dynamic landscape of operational risk management in the digital age. In today’s interconnected world, the fusion of cybersecurity and operational risk is paramount to business resilience. An effective operational risk framework needs to account for these cyber risks just as it does for other operational risks like technology failures, human errors, and natural disasters. In this talk, I’ll explain why cybersecurity needs to be a core focus of operational risk management, provide an overview of key cyber threats organisations face today, and discuss strategies for comprehensively assessing and mitigating cyber risks across the enterprise.
- 01Empowerment, experience, evidence — the impact of the patient voice
- 02Engagement delivers value as a triple win — for patients, for pharma, for society
- 03Ensuring voice to value in the ‘Patient 3.0’ era
CASE STUDY
The Novo Nordisk Development and Implementation of a Patient Voice Framework Across the Value Chain
By first of February Liselotte Hyveled was appointed Chief Patient Officer in Novo Nordisk. A new role in Novo Nordisk which comes with the ambition of innovating how we not only in Novo Nordisk but also in the industry are incorporating the Patient Voice throughout our development process with a systematic and documented approach. Hence, this presentation will provide you with insights to the journey Novo Nordisk are on to form a complete new unit and air an evolutionary framework to define how we from therapy area level to project level are working with the Patient Voice across the value chain, as well as providing concrete case study example.
- 01Why do we need to include patient perspectives to optimize integrated treatment solutions?
- 02What is our strategic intent by implementing Patient Voice in Novo Nordisk across the value chain and thereby implementing the role of a Chief Patient Officer and the new unit "Patient Voice Strategy & Alliance"?
- 03How do we use a Patient Voice framework in a fit for purpose way to ensure we can transform the way Novo Nordisk includes patient perspectives into our key decision process?
- 04Case study of Patient Voice activities in ClinOps and the benefits it brings
CASE STUDY
Clinical Trial Transparency
Clinical Trial Transparency is not only required by legal and regulatory rules and Pharma Associations’ Self Commitments, it also reflects the interest of sponsors in terms of clinical customer centricity. Registry of clinical trials and publishing results ensures up-to-date information for patients, caregivers, relatives, and physicians/ investigators. In accordance with Clinical Trials Regulations, lay language summaries of clinical trial results have to be provided.
- 01Legal/Regulatory Background of Clinical Trial Transparency
- 02Bayer’s Clinical Trial Explorer Website
- 03Lay Language Summaries – Bayer – internal processes
CASE STUDY
3 Patient Recruitment Learnings in Various Indications. Plus, a Bonus Must Have Requirement
An informative session where Andreas will explore intriguing learnings in patient recruitment tactics. Discover the effectiveness of print material in today’s digital age, uncover the power of compelling calls to action, and explore the impact of multilingual tactics with a planned, engaging presentation that will leave you with lessons from the most recent patient recruitment strategies. Lastly, Andreas will share his thoughts on the hottest 2024 patient recruitment requirement.
- 01Learning #1: Does print material work nowadays?
- 02Learning #2: Which call to action works more effectively and with whom?
- 03Learning #3: Do multilingual tactics work?
- 04Bonus requirement: Well, join to find out. #smile
CASE STUDY
Use of the Ethereum Blockchain Platform for Data Integrity and Security Management in Clinical Trials
The recent massive security breaches and data theft in the healthcare industry have made managing patient identities a very real problem. The blockchain can provide us with relevant solutions. Every pointer doctor records on the blockchain would become part of the patient’s record, regardless of the CRF that was used. The new tech transforms the data entry, and converts researchers into miners. The Tokenisation of Clinical Trials is coming and that is possible since the Ethereum Frontier repository was public in 2015. Considering an actual PESTELE analysis we can outline the risk, the weaknesses of a pharma or biotech at the present time. The presentation also emphasises the modification of Porter’s forces to make strategic decisions.
- 01Blockchain and GDRP (UE) 2016/679
- 02Mining requirements
- 03Healthcoins
CASE STUDY
Patient Experience Milestones in Clinical Trials: From Voice to Value
We delve into the dynamic landscape of operational risk management in the digital age. In today’s interconnected world, the fusion of cybersecurity and operational risk is paramount to business resilience. An effective operational risk framework needs to account for these cyber risks just as it does for other operational risks like technology failures, human errors, and natural disasters. In this talk, I’ll explain why cybersecurity needs to be a core focus of operational risk management, provide an overview of key cyber threats organisations face today, and discuss strategies for comprehensively assessing and mitigating cyber risks across the enterprise.
- 01Empowerment, experience, evidence — the impact of the patient voice
- 02Engagement delivers value as a triple win — for patients, for pharma, for society
- 03Ensuring voice to value in the ‘Patient 3.0’ era
CASE STUDY
The Novo Nordisk Development and Implementation of a Patient Voice Framework Across the Value Chain
By first of February Liselotte Hyveled was appointed Chief Patient Officer in Novo Nordisk. A new role in Novo Nordisk which comes with the ambition of innovating how we not only in Novo Nordisk but also in the industry are incorporating the Patient Voice throughout our development process with a systematic and documented approach. Hence, this presentation will provide you with insights to the journey Novo Nordisk are on to form a complete new unit and air an evolutionary framework to define how we from therapy area level to project level are working with the Patient Voice across the value chain, as well as providing concrete case study example.
- 01Why do we need to include patient perspectives to optimize integrated treatment solutions?
- 02What is our strategic intent by implementing Patient Voice in Novo Nordisk across the value chain and thereby implementing the role of a Chief Patient Officer and the new unit "Patient Voice Strategy & Alliance"?
- 03How do we use a Patient Voice framework in a fit for purpose way to ensure we can transform the way Novo Nordisk includes patient perspectives into our key decision process?
- 04Case study of Patient Voice activities in ClinOps and the benefits it brings
CASE STUDY
Clinical Trial Transparency
Clinical Trial Transparency is not only required by legal and regulatory rules and Pharma Associations’ Self Commitments, it also reflects the interest of sponsors in terms of clinical customer centricity. Registry of clinical trials and publishing results ensures up-to-date information for patients, caregivers, relatives, and physicians/ investigators. In accordance with Clinical Trials Regulations, lay language summaries of clinical trial results have to be provided.
- 01Legal/Regulatory Background of Clinical Trial Transparency
- 02Bayer’s Clinical Trial Explorer Website
- 03Lay Language Summaries – Bayer – internal processes
CASE STUDY
3 Patient Recruitment Learnings in Various Indications. Plus, a Bonus Must Have Requirement
An informative session where Andreas will explore intriguing learnings in patient recruitment tactics. Discover the effectiveness of print material in today’s digital age, uncover the power of compelling calls to action, and explore the impact of multilingual tactics with a planned, engaging presentation that will leave you with lessons from the most recent patient recruitment strategies. Lastly, Andreas will share his thoughts on the hottest 2024 patient recruitment requirement.
- 01Learning #1: Does print material work nowadays?
- 02Learning #2: Which call to action works more effectively and with whom?
- 03Learning #3: Do multilingual tactics work?
- 04Bonus requirement: Well, join to find out. #smile
CASE STUDY
Use of the Ethereum Blockchain Platform for Data Integrity and Security Management in Clinical Trials
The recent massive security breaches and data theft in the healthcare industry have made managing patient identities a very real problem. The blockchain can provide us with relevant solutions. Every pointer doctor records on the blockchain would become part of the patient’s record, regardless of the CRF that was used. The new tech transforms the data entry, and converts researchers into miners. The Tokenisation of Clinical Trials is coming and that is possible since the Ethereum Frontier repository was public in 2015. Considering an actual PESTELE analysis we can outline the risk, the weaknesses of a pharma or biotech at the present time. The presentation also emphasises the modification of Porter’s forces to make strategic decisions.
- 01Blockchain and GDRP (UE) 2016/679
- 02Mining requirements
- 03Healthcoins
CASE STUDY
Patient Experience Milestones in Clinical Trials: From Voice to Value
We delve into the dynamic landscape of operational risk management in the digital age. In today’s interconnected world, the fusion of cybersecurity and operational risk is paramount to business resilience. An effective operational risk framework needs to account for these cyber risks just as it does for other operational risks like technology failures, human errors, and natural disasters. In this talk, I’ll explain why cybersecurity needs to be a core focus of operational risk management, provide an overview of key cyber threats organisations face today, and discuss strategies for comprehensively assessing and mitigating cyber risks across the enterprise.
- 01Empowerment, experience, evidence — the impact of the patient voice
- 02Engagement delivers value as a triple win — for patients, for pharma, for society
- 03Ensuring voice to value in the ‘Patient 3.0’ era
CASE STUDY
The Novo Nordisk Development and Implementation of a Patient Voice Framework Across the Value Chain
By first of February Liselotte Hyveled was appointed Chief Patient Officer in Novo Nordisk. A new role in Novo Nordisk which comes with the ambition of innovating how we not only in Novo Nordisk but also in the industry are incorporating the Patient Voice throughout our development process with a systematic and documented approach. Hence, this presentation will provide you with insights to the journey Novo Nordisk are on to form a complete new unit and air an evolutionary framework to define how we from therapy area level to project level are working with the Patient Voice across the value chain, as well as providing concrete case study example.
- 01Why do we need to include patient perspectives to optimize integrated treatment solutions?
- 02What is our strategic intent by implementing Patient Voice in Novo Nordisk across the value chain and thereby implementing the role of a Chief Patient Officer and the new unit "Patient Voice Strategy & Alliance"?
- 03How do we use a Patient Voice framework in a fit for purpose way to ensure we can transform the way Novo Nordisk includes patient perspectives into our key decision process?
- 04Case study of Patient Voice activities in ClinOps and the benefits it brings
CASE STUDY
Clinical Trial Transparency
Clinical Trial Transparency is not only required by legal and regulatory rules and Pharma Associations’ Self Commitments, it also reflects the interest of sponsors in terms of clinical customer centricity. Registry of clinical trials and publishing results ensures up-to-date information for patients, caregivers, relatives, and physicians/ investigators. In accordance with Clinical Trials Regulations, lay language summaries of clinical trial results have to be provided.
- 01Legal/Regulatory Background of Clinical Trial Transparency
- 02Bayer’s Clinical Trial Explorer Website
- 03Lay Language Summaries – Bayer – internal processes
CASE STUDY
3 Patient Recruitment Learnings in Various Indications. Plus, a Bonus Must Have Requirement
An informative session where Andreas will explore intriguing learnings in patient recruitment tactics. Discover the effectiveness of print material in today’s digital age, uncover the power of compelling calls to action, and explore the impact of multilingual tactics with a planned, engaging presentation that will leave you with lessons from the most recent patient recruitment strategies. Lastly, Andreas will share his thoughts on the hottest 2024 patient recruitment requirement.
- 01Learning #1: Does print material work nowadays?
- 02Learning #2: Which call to action works more effectively and with whom?
- 03Learning #3: Do multilingual tactics work?
- 04Bonus requirement: Well, join to find out. #smile
Ahmed Nasr
Operations Director Egypt and Director Milk Africa & Turkey
Khaled Elsharkawy
Integrated Supply Chain Senior Director
Mueen Uddin Siddique
Senior Director – Access Network Procurement
Shannon Hore
Senior Vice President Procurement and Logistics
Sandeep Sharma
Director Group Procurement & International Markets Supply Chain
Hottest topics
LOOK AT THE TOPICS THAT WERE DISCUSSED
- 01Successful disease management and support programs in patient recruitment and retention
- 02The patient’s voice: Amplifying impact through advocacy in recruitment
- 03Patient-centric registry development: Engaging patients and communities in registry initiatives
- 04Patient assistance programs: Enhancing access and participation through support initiatives
- 05Data integrity matters: Strategies for precision and accuracy in protocols across pharma and observational research
- 06AI-driven patient identification: Leveraging artificial intelligence for targeted recruitment and efficiency
Testimonials
What our users say about our conferences
Another great conference, very interesting, interactive and a good opportunity for learning
GSK
Head of Clinical Operations UK and Ireland
Enjoyed the event, it was very valuable. Good variety of topics and presentations – taking away lots of good ideas.
Pfizer
Associate Director, Patient Recruitment Programmes
I really liked the atmosphere, interactive sessions, networking, professionalism and the quality of speakers.
The Janssen Pharmaceutical Companies of Johnson & Johnson
Director, Patient Engagement Strategy
Excellent conference. Great discussions. The size of this conference allows for great dialogues.
Ipsen
Global Patient Centricity Director
Sponsors
Our Trusted Sponsor at This Summit
Download our App to
Enhance Your Event Experience
This innovative app is aimed at enhancing your networking experience through a seamless blend of interaction and connectivity. We have carefully crafted this application with new features that empower you to make the most out of your engagements, ensuring personalised experiences and seamless networking opportunities.
STAY UPDATED FOR THE 2025 EDITION
Provide Us With Your Contact Details and Our Team Will Get Back to You
With All the Updates Regarding the Upcoming Edition of This Event.
With All the Updates Regarding the Upcoming Edition of This Event.